These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560 [TBL] [Abstract][Full Text] [Related]
5. Prediction of pathology and survival by FDG PET in gliomas. Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598 [TBL] [Abstract][Full Text] [Related]
6. The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients. Smith SF; Simpson JM; Brewer JA; Sekhon LH; Biggs MT; Cook RJ; Little NS J Neurooncol; 2006 Oct; 80(1):75-82. PubMed ID: 16794749 [TBL] [Abstract][Full Text] [Related]
7. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related]
10. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas. Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas. Dahlrot RH Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818 [TBL] [Abstract][Full Text] [Related]
13. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study. Yang W; Xu T; Garzon-Muvdi T; Jiang C; Huang J; Chaichana KL World Neurosurg; 2018 Mar; 111():e323-e334. PubMed ID: 29258929 [TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093 [TBL] [Abstract][Full Text] [Related]
17. Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma. Gzell C; Wheeler H; Huang D; Gaur P; Chen J; Kastelan M; Back M Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):215-22. PubMed ID: 26382848 [TBL] [Abstract][Full Text] [Related]
18. Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index. Yan R; Haopeng P; Xiaoyuan F; Jinsong W; Jiawen Z; Chengjun Y; Tianming Q; Ji X; Mao S; Yueyue D; Yong Z; Jianfeng L; Zhenwei Y Neuroradiology; 2016 Feb; 58(2):121-32. PubMed ID: 26494463 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
20. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours. Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]